Back to search

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study

Data up to Jan 2025

Published2013
Citations255
References27

Total Citations Per Year

Abstract

References (27)

External review and validation of the Swedish national inpatient register

2011 • 4,308 citations

The Danish Civil Registration System

2011 • 4,056 citations

The Danish National Patient Register

2011 • 3,530 citations

The Danish National Prescription Registry

2011 • 2,130 citations

The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

2009 • 2,072 citations

The Danish Civil Registration System. A cohort of eight million persons.

2006 • 1,582 citations

The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months

2006 • 1,564 citations

AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland

2012 • 488 citations

Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine

2009 • 461 citations

Vaccination and autoimmune disease: what is the evidence?

2003 • 351 citations

Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis

2011 • 276 citations

Case Series Analysis of Adverse Reactions to Vaccines: A Comparative Evaluation

1996 • 230 citations

Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink

2011 • 218 citations

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis

2013 • 206 citations

Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: A pooled analysis of 11 clinical trials

2009 • 196 citations

Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine

2011 • 188 citations

Parental Knowledge, Attitudes, and Behaviours towards Human Papillomavirus Vaccination for Their Children: A Systematic Review from 2001 to 2011

2011 • 156 citations

Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to Females

2012 • 112 citations

Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine

2010 • 112 citations

An update on human papillomavirus vaccine uptake among 11–17 year old girls in the United States: National Health Interview Survey, 2010

2012 • 111 citations

Postlicensure epidemiology of childhood vaccination: the Danish experience

2006 • 46 citations

Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine

2009 • 33 citations

Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study

2012 • 28 citations

Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands

2011 • 25 citations

Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events

2009 • 22 citations

Autoimmune diseases after adolescent or adult immunization: What should we expect?

2007 • 19 citations

Evaluation of autoimmune safety signal in observational vaccine safety studies

2012 • 10 citations

Cited By (0)

No citing papers found in database

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of… (2013) – BMJ | Metascience Observatory Explorer